ACCESSWIRE
23 May 2023, 14:55 GMT+10
PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / May 23, 2023 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series D round of financing, raising €50 million from new and existing international investors, including Fonds Stratégique des Transitions, managed by ISALT, Merieux Developpement and returning Cathay Health, Credit Mutuel Innovation and Sofinnova Partners.
This latest funding round coincides with a period of important milestones for TISSIUM, notably its on-going first-in-human study on its first nerve repair product, COAPTIUM Connect, in Australia and multiple on-going regulatory activities. The financing will allow TISSIUM to continue to execute on its development plan, funding the company for the commercialisation of its first products in nerve and hernia repair and fueling the extension of its pipeline of products and its platform.
As TISSIUM adds to its platform with products in new therapeutic areas, it will continue to pursue rapid international expansion, leveraging in-house production and state-of-the-art manufacturing facilities, as well as entering partnerships in certain verticals.
Christophe Bancel, CEO of TISSIUM, said, 'With the closing of our Series D financing round, TISSIUM is well-positioned to finance the commercialization of its first products. This funding significantly bolsters our ability to move with speed towards our goal of enhancing tissue reconstruction for patients. We look forward to continuing our work to bring innovation in the space and develop products that make a difference in patients' lives.'
About TISSIUM:
TISSIUM, a privately-owned MedTech company based in Paris, France and Boston, USA, is dedicated to the development and commercialization of products derived from its unique biopolymer platform. The company's products will address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction.
TISSIUM is developing a portfolio of products that leverage its proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are the foundation of the company's technology platform. Currently, the Company has a pipeline of seven products across three verticals, including sutureless nerve repair, hernia repair and cardiovascular sealants. Each product is designed to enhance the tissue reconstruction process in a unique way. In addition, the company develops complementary delivery and activation devices for enhanced performance and usability of its products.
TISSIUM's technology is based on world-class research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company in 2013.
For more information, please visit: www.TISSIUM.com
Follow us on LinkedIn, Twitter @TISSIUMtech.
###
CONTACTS
Investor relations
Romain Attard - Chief Financial Officer rattard@tissium.com
Tel: +33 1 76 21 72 28 Twitter: @TISSIUMtech
Press
Jeanene Timberlake jtimberlake@rooneypartners.com
Tel: +1 646-770-8858
SOURCE: TISSIUM
Get a daily dose of Orange County Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Orange County Sun.
More InformationABUJA, Nigeria - Bola Tinubu became Nigeria's president Monday during a period of unprecedented challenges for Africa's most populous country, ...
Chicago White Sox right-hander Liam Hendricks was placed on the active roster Monday and is set to make his return ...
tehran, iran - Iran's Supreme Leader Ayatollah Ali Khamenei said Monday he would welcome a resumption of diplomatic relations with ...
Marcus Stroman tossed a one-hitter for his fourth career complete game to dominate the Tampa Bay Rays, and the Chicago ...
Cardinals All-Star Nolan Arenado opened the bottom of the eighth inning with a clean line-drive single into left field off ...
The Kansas City Royals are working on what would be the first combined perfect game in baseball history against the ...
WASHINGTON D.C.: The White House announced this week that President Joe Biden has chosen US Air Force chief General Charles ...
GUAM: After Typhoon Mawar brought strong winds and torrential rains, large areas of the US Western Pacific territory of Guam ...
NEW YORK CITY, New York: In one of the largest known Chinese cyber-espionage campaigns against American critical infrastructure, a state-sponsored ...
SAN FRANCISCO, California: Sam Altman, CEO of ChatGPT-maker OpenAI, has said the company could consider leaving Europe if it could ...
WASHINGTON D.C.: Reuters has reported that US President Joe Biden's nominee for a federal judge position in Kansas, Jabari Wamble, ...
WASHINGTON D.C.: Jennifer Homendy, head of the US National Transportation Safety Board, has said the US will investigate recent near ...